Animal Drug User Fee Act; Public Meeting; Request for Comments
Details
The document's own metadata, straight from the source system.
- Title
- Animal Drug User Fee Act; Public Meeting; Request for Comments
- Posted
- Apr 17, 2026
- Comment period
- Apr 17, 2026 – Dec 2, 2027
- FR Doc
- 2026-07498
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Adufa reauthorization | Modernization of animal drug review |
|---|
2 organization-typed comments could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jun 6, 2026Comment from Molly Knight FordeSupportIndividual
The commenter supports the reauthorization of the Animal Drug User Fee Act (ADUFA) but argues that the FDA should seek expanded authority from Congress. They specifically advocate for the ability to mandate label changes to mitigate public health risks, such as antibiotic resistance, resulting from the use of veterinary drugs in food animals.
Read comment → - May 28, 2026Comment from Animal Health Institute (AHI)SupportTrade association📎 Attachment
The Animal Health Institute (AHI), a trade association representing animal medicine companies, supports the ADUFA VI reauthorization process. They advocate for a modernized framework that prioritizes speed, innovation, and international harmonization to improve timely access to animal health products.
Read comment → - May 28, 2026Comment from Animal Health Institute (AHI)SupportTrade association📎 Attachment
The Animal Health Institute (AHI), a trade association representing animal medicine companies, supports the ADUFA VI reauthorization process. They advocate for a modernized framework that prioritizes speed, innovation, and international harmonization to improve timely access to animal health products.
Read comment →